Yutong Liu

Suita, 5650871, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Journal: Scientific reports

Published: April 02, 2026

SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma.

SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell Carcinoma.

Journal: Anticancer research

Published: December 02, 2025

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 20, 2025

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Bone scan index rise prior to osteonecrosis of the jaw with bone-modifying agents in prostate cancer.

Journal: BJUI compass

Published: October 16, 2025

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Journal: Cancer science

Published: August 13, 2025

Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer.

Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer.

Journal: Cancer science

Published: April 01, 2025

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases.

Journal: Anticancer research

Published: December 20, 2024

PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide.

PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide.

Journal: Cancer diagnosis & prognosis

Published: August 14, 2024

Bacterial information in serum extracellular vesicles reflects the inflammation of adherent perinephric fat.

Bacterial information in serum extracellular vesicles reflects the inflammation of adherent perinephric fat.

Journal: Cancer science

Published: August 02, 2024

Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management.

Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management.

Journal: Scientific reports

Published: February 28, 2024

Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects.

Liquid Biomarkers in Prostate Cancer Diagnosis: Current Status and Emerging Prospects.

Journal: The world journal of men's health

Published: December 31, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026